PL370624A1 - Sposoby leczenia infekcji bakteryjnych u psów i kotów - Google Patents

Sposoby leczenia infekcji bakteryjnych u psów i kotów

Info

Publication number
PL370624A1
PL370624A1 PL02370624A PL37062402A PL370624A1 PL 370624 A1 PL370624 A1 PL 370624A1 PL 02370624 A PL02370624 A PL 02370624A PL 37062402 A PL37062402 A PL 37062402A PL 370624 A1 PL370624 A1 PL 370624A1
Authority
PL
Poland
Prior art keywords
cats
dogs
methods
bacterial infections
treating bacterial
Prior art date
Application number
PL02370624A
Other languages
English (en)
Inventor
Simon Edward Blanchflower
Brian Scott Bronk
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0130694.3A external-priority patent/GB0130694D0/en
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of PL370624A1 publication Critical patent/PL370624A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
PL02370624A 2001-12-21 2002-11-13 Sposoby leczenia infekcji bakteryjnych u psów i kotów PL370624A1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0130694.3A GB0130694D0 (en) 2001-12-21 2001-12-21 Treatment
US35996102P 2002-02-27 2002-02-27
US39893302P 2002-07-26 2002-07-26

Publications (1)

Publication Number Publication Date
PL370624A1 true PL370624A1 (pl) 2005-05-30

Family

ID=27256361

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02370624A PL370624A1 (pl) 2001-12-21 2002-11-13 Sposoby leczenia infekcji bakteryjnych u psów i kotów

Country Status (12)

Country Link
EP (1) EP1455900A1 (pl)
JP (1) JP2005524611A (pl)
CN (1) CN1606463A (pl)
AR (1) AR037594A1 (pl)
AU (1) AU2002348985A1 (pl)
BR (1) BR0215070A (pl)
CA (1) CA2470995A1 (pl)
IL (1) IL162103A0 (pl)
NO (1) NO20043008L (pl)
PL (1) PL370624A1 (pl)
TW (1) TW200301126A (pl)
WO (1) WO2003053522A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007533724A (ja) * 2004-04-22 2007-11-22 ファイザー・プロダクツ・インク 無秩序なセフォベシンナトリウム塩を安定させる方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0395219T3 (da) * 1989-03-30 1999-02-15 Pfizer Cephalosporiner og deres homologer, fremgangsmåde til deres fremstilling og farmaceutiske præparater
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation

Also Published As

Publication number Publication date
AU2002348985A1 (en) 2003-07-09
NO20043008L (no) 2004-09-01
WO2003053522A1 (en) 2003-07-03
JP2005524611A (ja) 2005-08-18
TW200301126A (en) 2003-07-01
CA2470995A1 (en) 2003-07-03
BR0215070A (pt) 2004-11-09
IL162103A0 (en) 2005-11-20
EP1455900A1 (en) 2004-09-15
AR037594A1 (es) 2004-11-17
CN1606463A (zh) 2005-04-13

Similar Documents

Publication Publication Date Title
IL161851A0 (en) Formulations comprising a cephalosporin compound and their use treating bacterial infections in catsand dogs
IL165252A0 (en) Compositions and method for treating infection in cattle and swine
IL172224A0 (en) Compositions for treating infection in cattle and swine
EP1531828A4 (en) METHODS OF TREATING BACTERIAL INFECTIONS AND ASSOCIATED DISEASES
AU2003290867A8 (en) Methods and products for treating staphylococcal infections
AU2001294593A1 (en) Method of treating aquatic animals with an antimicrobial agent and chelating agent
NO20025204D0 (no) Forbindelser og fremgangsmÕter for behandling og forebygging av bakterielle infeksjoner
EP1383374A4 (en) DEVICE AND METHOD FOR TRAINING ANIMALS
AU8878801A (en) Agent and method of prevention and treatment of cancer in animals
ZA200507857B (en) Compositions for treating microbial and parasitic infections in cattle and other animals
IL169701A0 (en) The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
EP1389972A4 (en) Animal treatment and marking system
AU2003239132A8 (en) Methods and compositions for preventing and treating microbial infections
MXPA03003309A (es) Tratamiento y profilaxis de enfermedades e infecciones de cerdos de corral.
IL162103A0 (en) Methods of treating bacterial infections in dogs and cats
EP1233967A4 (en) PYRIDINONES FOR THE TREATMENT AND PREVENTION OF BACTERIAL INFECTIONS
AU2003290506A8 (en) Methods and devices for treating severe peripheral bacterial infections
ZA200500166B (en) Methods of treating microbial infections in humans and animals
GB0323849D0 (en) Animal treatment system and method thereof
AU2002211637A1 (en) Probiotic compositions and methods against bacterial infection in livestock animals
HUP0200466A3 (en) Lipoglycan compositions and methods of treating parasitic infections
HUP0301298A3 (en) Anthelminthic agents for the prevention of parasitic infections in humans and animals ii
GB2376628B (en) Treatment of DNA viral infections in cats
AU2003267962A8 (en) Antibacterial compounds and methods for treating gram positive bacterial infections
AU2002229446A1 (en) Hog farming process and barn

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)